Intellipharmaceutics International Inc. (IPCI)

0.2106 -0.0594 (-22%)

IEX Real-Time Price

March 20, 2019 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.27

Price Open 0.21

Volume: 2.29M

Avg Volume: 1.4M

Market Cap: 4.62M

P/E Ratio -0.07

52 Wk Range 0.2001-6.6



IPCI Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
42.78M
865,372
1.65
2.02%

2018-09-28
4.35M
284,872
5.33
6.54%

2018-09-14
4.35M
277,913
8.10
6.38%

2018-08-31
43.54M
2.28M
12.48
5.24%




IPCI Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-03-01
Q4 2018
N/A
0.00 (0)
0.00
0.00

2018-11-13
Q3 2018
N/A
0.00 (0)
0.00
0.00

2018-10-30
Q3 2018
N/A
0.00 (0)
0.00
0.00

2018-10-15
Q3 2018
N/A
0.00 (0)
-0.91
0.00

News

IntelliPharmaCeutics reports FY results (2019-02-22 17:28 SeekingAlpha)

IntelliPharmaCeutics (NASDAQ: IPCI ): FY GAAP EPS of -$2.89. More news on: IntelliPharmaCeutics International Inc, Earnings news and commentary, Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 21.93M

Top 15 Institution Percent: 10.70

Price To Sales: 3.95

Price To Book: 1.48

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -147.45

Return On Equity: -614.14

Profit Margin: N/A

Price History

Beta: 2.15

50-day Moving Avg: 0.31

200-day Moving Avg: 1.81

YTD Change: -18.18

5-day Change: -19.92

1-month Change: -38.06

3-month Change: -18.94

6-month Change: -92.29

1-year Change: -96.76

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Intellipharmaceutics International Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs.